echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Brit J Cancer: Changes in bone density in post-menoptocras for 5 years after treatment with anatreptide

    Brit J Cancer: Changes in bone density in post-menoptocras for 5 years after treatment with anatreptide

    • Last Update: 2021-03-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    During the treatment of anatrobolic, it was associated with significantly accelerated bone density (BMD) loss.
    , researchers included 1,410 post-menopause women in the BMD subgroup, with a baseline T score of three levels based on their spine or collar, according to a recent study published in British Journal of Cancer, an authoritative journal in the field of oncology.
    The main purpose of this analysis was to investigate whether BMD measured by the bier energy X-ray absorption assay (DXA) of the spine and hips changed two years after discontinuation of treatment (year 5 to 7).
    528 women who were not treated with bisphosphonate received BMD data for five and seven years.
    In women with normal BMD at baseline, the researchers observed a 1.25% increase in lumbar BMD after anatrophosopy (95% CI is 0.73-1.77) (P-0.0004), a significant increase over the placebo group (-0.29-0.56).
    hips, BMD remained unchanged for 5-7 years in patients taking the anatrophotosis group, while BMD, randomly assigned to the comfort group, continued to decline (-1.35% (-1.70 to -0.98).
    , this is the first study to report stopping BMD changes in anatrophospons in breast cancer patients.
    the results of this study show that the negative effects of anatroconol on preventing breast cancer on BMD are reversible.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.